Science Explorer Interactive view Map
Company · Berlin · Germany

Noxxon Pharma (Germany)

noxxon.comROR OpenAlex
Research works
84
▼ 77% vs 2013–17
Citations
3.9k
46.5 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
43%
world 28%

Not ranked overall: Noxxon Pharma (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

What does Noxxon Pharma (Germany) specialise in?

Where its research is concentrated relative to its size: Molecular Biology takes 10.6× the share of its output that it takes of world research.

  1. Molecular BiologySubfield · 35.6 works11×
  2. Biochemistry, Genetics and Molecular BiologyField · 39.6 works6.8×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Noxxon Pharma (Germany)?

Ranked on the composite score, Sven Klußmann lead among researchers whose main affiliation is Noxxon Pharma (Germany).

  1. 1 Sven Klußmann Germany · #255,863 worldwide 129 citations · 19 works
All ranked researchers at Noxxon Pharma (Germany)

Which keywords describe research at Noxxon Pharma (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Therapeutic Targets, Nanoparticles, Biosensors, Self-Assembly, aptamers, DNA nanotechnology, Nucleic Acids and DNA Structure.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Therapeutic Targets12▲ 59×4 topics
  2. Nanoparticles10▲ 8.7×6 topics
  3. Biosensors9▲ 18×3 topics
  4. Self-Assembly9▲ 26×4 topics
  5. DNA nanotechnology8▲ 96×1 topic
  6. aptamers8▲ 96×1 topic
  7. Inflammation8▲ 4.1×21 topics
  8. Nucleic Acids7▲ 108×2 topics
  9. DNA Structure7▲ 127×1 topic
  10. G-Quadruplexes7▲ 127×1 topic
  11. Translation6▲ 36×2 topics
  12. RNA Structure6▲ 73×1 topic
  13. Ribosome6▲ 73×1 topic
  14. Angiogenesis4▲ 13×6 topics
  15. Gene Therapy4▲ 19×3 topics
  16. Cell Migration4▲ 58×2 topics
  17. Cancer4▲ 3.4×13 topics
  18. Innate Immunity4▲ 13×8 topics
  19. Cancer Metastasis4▲ 137×2 topics
  20. Host Defense4▲ 67×2 topics
  21. Tumor Microenvironment4▲ 13×6 topics
  22. Chemokine Receptors4▲ 269×1 topic
  23. Chemokines4▲ 269×1 topic
  24. RNA Interference4▲ 37×1 topic
  25. siRNA Delivery4▲ 55×1 topic
  26. Drug Discovery3▲ 8.9×4 topics
  27. Immune Checkpoint Blockade2▲ 52×1 topic
  28. PD-1 and PD-L12▲ 52×1 topic
  29. Immunity2▲ 7.8×3 topics
  30. Glycosylation2▲ 11×2 topics
  31. Prognostic Factors2▲ 4.8×2 topics
  32. Hormonal Regulation2▲ 39×2 topics
  33. Ghrelin2▲ 60×1 topic
  34. Leptin2▲ 60×1 topic
  35. Cancer Immunotherapy2▲ 13×1 topic
  36. Dendritic Cells2▲ 16×1 topic
  37. PET Imaging2▲ 8.6×4 topics
  38. Rituximab2▲ 12×4 topics
  39. Gene Regulation1▲ 11×3 topics
  40. Targeted Therapy1▲ 7.7×3 topics

Which research topics does Noxxon Pharma (Germany) publish most on?

By volume in 2022–2025: Graphene and Nanomaterials Applications, Graphene research and applications, Palliative Care and End-of-Life Issues and Advanced biosensing and bioanalysis techniques.

Graphene and Nanomateria…0Graphene and Nanomaterials Applications: 0 fractional worksGraphene research and ap…0Graphene research and applications: 0 fractional worksPalliative Care and End-…0Palliative Care and End-of-Life Issues: 0 fractional worksAdvanced biosensing and …0Advanced biosensing and bioanalysis techniques: 0 fractional worksNanowire Synthesis and A…0Nanowire Synthesis and Applications: 0 fractional worksChildhood Cancer Survivo…0Childhood Cancer Survivors' Quality of Life: 0 fractional worksFrailty in Older Adults0Frailty in Older Adults: 0 fractional works
Biomedical EngineeringMaterials ChemistryPublic Health, Environmental and Occupational HealthMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Graphene and Nanomaterials Applications Biomedical Engineering 0 works
  2. 2 Graphene research and applications Materials Chemistry 0 works
  3. 3 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 0 works
  4. 4 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
  5. 5 Nanowire Synthesis and Applications Biomedical Engineering 0 works
  6. 6 Childhood Cancer Survivors' Quality of Life Pediatrics, Perinatology and Child Health 0 works
  7. 7 Frailty in Older Adults Geriatrics and Gerontology 0 works
  8. 8 Surface Chemistry and Catalysis Biomedical Engineering 0 works
  9. 9 DNA and Nucleic Acid Chemistry Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available43.0%not open57.0%

World: 28% of research is openly available.

with international co-authors34.4%domestic only65.6%

World: 19% is written across borders.

How has Noxxon Pharma (Germany)'s research output changed?

Output in 2018–2022 was 77% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Berlin

All research institutions in Berlin

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.